ES2144520T3 - Vehiculos farmaceuticos oftalmicos topicos. - Google Patents

Vehiculos farmaceuticos oftalmicos topicos.

Info

Publication number
ES2144520T3
ES2144520T3 ES94914698T ES94914698T ES2144520T3 ES 2144520 T3 ES2144520 T3 ES 2144520T3 ES 94914698 T ES94914698 T ES 94914698T ES 94914698 T ES94914698 T ES 94914698T ES 2144520 T3 ES2144520 T3 ES 2144520T3
Authority
ES
Spain
Prior art keywords
oftalmic
topics
pharmaceutical vehicles
instillation
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94914698T
Other languages
English (en)
Inventor
Yusuf Ali
Kenneth W Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22236869&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2144520(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of ES2144520T3 publication Critical patent/ES2144520T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTAN VEHICULOS FARMACOLOGICOS, OFTAMOLOGICOS, UNIVERSALES QUE INCREMENTAN SU VISCOSIDAD DESPUES DE SU APLICACION EN EL OJO. TAMBIEN SE PRESENTAN COMPOSICIONES OFTALMOLOGICAS DEL VEHICULO UNIVERSAL Y DROGAS FARMACOLOGICAMENTE ACTIVAS. EN UNA CONFORMACION, EL VEHICULO SE GELIFICA DESPUES DE SU INSTALACION EN EL OJO. EN OTRA CONFORMACION, SE SUMINISTRAN VEHICULOS QUE TIENEN UNA ESTABILIDAD FISICA SUPERIOR.
ES94914698T 1993-08-20 1994-02-16 Vehiculos farmaceuticos oftalmicos topicos. Expired - Lifetime ES2144520T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/007859 WO1995005803A1 (en) 1993-08-20 1993-08-20 Topical ophthalmic pharmaceutical vehicles

Publications (1)

Publication Number Publication Date
ES2144520T3 true ES2144520T3 (es) 2000-06-16

Family

ID=22236869

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94914698T Expired - Lifetime ES2144520T3 (es) 1993-08-20 1994-02-16 Vehiculos farmaceuticos oftalmicos topicos.

Country Status (11)

Country Link
EP (1) EP0665741B1 (es)
JP (1) JP2928641B2 (es)
AT (1) ATE191845T1 (es)
AU (2) AU5084693A (es)
CA (1) CA2147362C (es)
DE (1) DE69424033T2 (es)
DK (1) DK0665741T3 (es)
ES (1) ES2144520T3 (es)
GR (1) GR3033407T3 (es)
HK (1) HK1012555A1 (es)
WO (2) WO1995005803A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
FR2777189B1 (fr) * 1998-04-09 2001-04-06 Chauvin Lab Sa Composition ophtalmique comprenant un beta-bloquant
EP1135418A1 (en) * 1998-11-13 2001-09-26 CP Kelco U.S., Inc. Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
ATE444732T1 (de) * 2003-08-07 2009-10-15 Allergan Inc Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
EP1906949B1 (en) 2005-07-01 2015-02-11 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
JPWO2008001872A1 (ja) 2006-06-28 2009-11-26 ロート製薬株式会社 アルギン酸又はその塩を含有する眼科用組成物
TWI580441B (zh) 2008-09-19 2017-05-01 愛爾康研究有限公司 穩定的藥學次微米懸浮液及其形成方法
ITMI20091968A1 (it) * 2009-11-11 2011-05-12 Claudia Battaglino Composizione oftalmica
ITMI20091969A1 (it) * 2009-11-11 2011-05-12 Claudia Battaglino Composizione oftalmica
US9782345B2 (en) 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
CN118146569A (zh) * 2024-01-24 2024-06-07 中国海洋大学 透明质酸-青蒿琥酯-聚精氨酸纳米粒、制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions

Also Published As

Publication number Publication date
DE69424033D1 (de) 2000-05-25
DE69424033T2 (de) 2000-09-14
AU6696294A (en) 1995-03-21
CA2147362A1 (en) 1995-03-02
EP0665741A1 (en) 1995-08-09
WO1995005803A1 (en) 1995-03-02
EP0665741B1 (en) 2000-04-19
HK1012555A1 (en) 1999-08-06
AU5084693A (en) 1995-03-21
GR3033407T3 (en) 2000-09-29
WO1995005804A1 (en) 1995-03-02
JP2928641B2 (ja) 1999-08-03
JPH08502761A (ja) 1996-03-26
ATE191845T1 (de) 2000-05-15
DK0665741T3 (da) 2000-12-04
AU676911B2 (en) 1997-03-27
CA2147362C (en) 1999-03-16

Similar Documents

Publication Publication Date Title
ES2144520T3 (es) Vehiculos farmaceuticos oftalmicos topicos.
CA2322579A1 (en) Gelling ophthalmic compositions containing xanthan gum
DK0725628T3 (da) Termisk geldannende lægemiddelindgivelsesvehikler indeholdende celluloseethere
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
CA2090404A1 (en) Nonaqueous fluorinated drug delivery vehicle suspensions
CA2059403A1 (en) Use of Carrageenans in Topical Ophthalmic Compositions
BR0215238A (pt) Uso de nanopartìculas inor ânicas sintéticas como veìculos para drogas oftálmicas e óticas
ES8507573A1 (es) Procedimiento para la fabricacion de fracciones de acido hialuronico
CA2044676A1 (en) Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
AU1916995A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity
BR9306848A (pt) Anel polimérico dividido para introdução no estroma
DE68900170D1 (de) Verformbare haut fuer den uebergangsschutz zwischen zwei eisenbahn- oder strassenfahrzeugen.
PL316449A1 (en) Combinations of thrombolytically active proteins and coagulants and their application
ES2095975T3 (es) Uso de combinaciones de polisacaridos gelificantes y substratos portadores de medicamento, finamente divididos, para composiciones oftalmicas de uso topico.
ATE345780T1 (de) Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
FR2712593B1 (fr) Nouvelles spirooxazines et leur utilisation dans le domaine de l'optique ophtalmique.
DK1189595T3 (da) Ophthalmiske sammensætninger i form af vandige geler
FR2718446B1 (fr) Spiro [fluorène-[2H]-benzopyranes] hétéroannélés et leur utilisation dans le domaine de l'optique ophtalmique.
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
IT1241994B (it) Composizione farmaceutica ad effetto cicatrizzante.
IL104328A (en) Ocular drug delivery vehicles consisting of submicron emulsions and ophthalmic compositions comprising drugs and said vehicles
BR9814497A (pt) Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular
ZA9369B (en) Submicron emulsions as ocular drug delivery vehicles.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 665741

Country of ref document: ES